Literature DB >> 24496449

Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling.

Mariana Capurro1, Tonya Martin, Wen Shi, Jorge Filmus.   

Abstract

Glypican-3 (GPC3) is a proteoglycan that is bound to the cell surface. It is expressed by most hepatocellular carcinomas (HCCs) but not by normal hepatocytes. GPC3 stimulates HCC growth by promoting canonical Wnt signaling. Because glypicans interact with Wnts, it has been proposed that these proteoglycans stimulate signaling by increasing the amount of Wnt at the cell membrane, thus facilitating the interaction of this growth factor with its signaling receptor, Frizzled. However, in this study, we demonstrate that GPC3 plays a more direct role in the stimulation of Wnt signaling. Specifically, we show that, in addition to interacting with Wnt, GPC3 and Frizzled interact directly through the glycosaminoglycan chains of GPC3, indicating that this glypican stimulates the formation of signaling complexes between Wnt and Frizzled. Consistent with this, we show that the binding of Wnt at the cell membrane triggers the endocytosis of a complex that includes Wnt, Frizzled and GPC3. Additional support for our model is provided by the finding that glypican-6 (GPC6) inhibits canonical Wnt signaling, despite the fact that it binds to Wnt at the cell membrane.

Entities:  

Keywords:  Frizzled; Glypican-3; Heparan sulphate; Hepatocellular carcinoma; Proteoglycan; Wnt

Mesh:

Substances:

Year:  2014        PMID: 24496449     DOI: 10.1242/jcs.140871

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  63 in total

1.  A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice.

Authors:  Na Li; Liwen Wei; Xiaoyu Liu; Hongjun Bai; Yvonne Ye; Dan Li; Nan Li; Ulrich Baxa; Qun Wang; Ling Lv; Yun Chen; Mingqian Feng; Byungkook Lee; Wei Gao; Mitchell Ho
Journal:  Hepatology       Date:  2019-05-24       Impact factor: 17.425

2.  Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.

Authors:  Dolores Fernández; Macarena Guereño; María Amparo Lago Huvelle; Magalí Cercato; María Giselle Peters
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-28       Impact factor: 4.553

Review 3.  Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis.

Authors:  Isao Matsuo; Chiharu Kimura-Yoshida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-12-05       Impact factor: 6.237

Review 4.  Extracellular heparan sulfate proteoglycans and glycan-binding lectins orchestrate trans-synaptic signaling.

Authors:  Emma Rushton; Danielle L Kopke; Kendal Broadie
Journal:  J Cell Sci       Date:  2020-08-11       Impact factor: 5.285

Review 5.  Liver regeneration: biological and pathological mechanisms and implications.

Authors:  George K Michalopoulos; Bharat Bhushan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-06       Impact factor: 46.802

6.  Immunohistochemical expression of glypican 3 in endometrial carcinoma and correlation with prognostic parameters.

Authors:  Sarah A Hakim; Nermine M Abd Raboh
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.

Authors:  S Yuan; Z Yu; Q Liu; M Zhang; Y Xiang; N Wu; L Wu; Z Hu; B Xu; T Cai; X Ma; Y Zhang; C Liao; L Wang; P Yang; L Bai; Y Li
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

Review 8.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

9.  An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells.

Authors:  Kévin Ly; Rachid Essalmani; Roxane Desjardins; Nabil G Seidah; Robert Day
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

Review 10.  Glypicans as Cancer Therapeutic Targets.

Authors:  Nan Li; Wei Gao; Yi-Fan Zhang; Mitchell Ho
Journal:  Trends Cancer       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.